Valneva SE (VALN)
USD 3.71
(0.59%)
USD 3.71
(0.59%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 132.76 Million EUR | 15.06% |
| 2022 | 115.39 Million EUR | 10.51% |
| 2021 | 104.41 Million EUR | 9.03% |
| 2020 | 95.76 Million EUR | 18.36% |
| 2019 | 80.9 Million EUR | 101.92% |
| 2018 | 40.07 Million EUR | -25.93% |
| 2017 | 54.09 Million EUR | -12.1% |
| 2016 | 61.54 Million EUR | -19.62% |
| 2015 | 76.56 Million EUR | 15.95% |
| 2014 | 66.03 Million EUR | 1.75% |
| 2013 | 64.9 Million EUR | 1179.36% |
| 2012 | 5.07 Million EUR | -3.7% |
| 2011 | 5.26 Million EUR | -4.93% |
| 2010 | 5.54 Million EUR | 3.36% |
| 2009 | 5.36 Million EUR | 38.74% |
| 2008 | 3.86 Million EUR | 23.69% |
| 2007 | 3.12 Million EUR | 8.17% |
| 2006 | 2.88 Million EUR | 6.61% |
| 2005 | 2.7 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 160.54 Million EUR | 0.95% |
| 2024 Q1 | 159.03 Million EUR | 19.78% |
| 2023 Q4 | 132.76 Million EUR | -1.58% |
| 2023 Q1 | 112.78 Million USD | -2.26% |
| 2023 FY | 132.76 Million EUR | 15.06% |
| 2023 Q2 | 102.09 Million EUR | -9.47% |
| 2023 Q3 | 134.89 Million EUR | 32.13% |
| 2022 Q2 | 118.98 Million EUR | 147.87% |
| 2022 Q3 | 146 Million EUR | 22.71% |
| 2022 Q4 | 115.39 Million EUR | -20.97% |
| 2022 FY | 115.39 Million EUR | 10.51% |
| 2022 Q1 | 48 Million EUR | -54.02% |
| 2021 Q4 | 104.41 Million EUR | 0.0% |
| 2021 FY | 104.41 Million EUR | 9.03% |
| 2021 Q2 | 101.31 Million EUR | 3.96% |
| 2021 Q1 | 97.46 Million EUR | 1.77% |
| 2020 Q4 | 95.76 Million EUR | -5.39% |
| 2020 FY | 95.76 Million EUR | 18.36% |
| 2020 Q1 | 90.84 Million EUR | 12.28% |
| 2020 Q2 | 102.72 Million EUR | 13.08% |
| 2020 Q3 | 101.21 Million EUR | -1.47% |
| 2019 Q2 | 70.02 Million EUR | -3.13% |
| 2019 FY | 80.9 Million EUR | 101.92% |
| 2019 Q1 | 72.28 Million EUR | 80.39% |
| 2019 Q4 | 80.9 Million EUR | 1.05% |
| 2019 Q3 | 80.06 Million EUR | 14.35% |
| 2018 Q4 | 40.07 Million EUR | -0.61% |
| 2018 Q3 | 40.31 Million EUR | 3.29% |
| 2018 Q2 | 39.03 Million EUR | -5.16% |
| 2018 Q1 | 41.15 Million EUR | -23.92% |
| 2018 FY | 40.07 Million EUR | -25.93% |
| 2017 Q3 | 51.97 Million EUR | -4.01% |
| 2017 Q4 | 54.09 Million EUR | 4.08% |
| 2017 FY | 54.09 Million EUR | -12.1% |
| 2017 Q2 | 54.14 Million EUR | -5.88% |
| 2017 Q1 | 57.52 Million EUR | -6.53% |
| 2016 Q2 | 64.81 Million EUR | -7.39% |
| 2016 FY | 61.54 Million EUR | -19.62% |
| 2016 Q4 | 61.54 Million EUR | -2.1% |
| 2016 Q3 | 62.86 Million EUR | -3.01% |
| 2016 Q1 | 69.98 Million EUR | -8.59% |
| 2015 Q2 | 83.38 Million EUR | -3.1% |
| 2015 FY | 76.56 Million EUR | 15.95% |
| 2015 Q3 | 80.81 Million EUR | -3.08% |
| 2015 Q4 | 76.56 Million EUR | -5.26% |
| 2015 Q1 | 86.05 Million EUR | 30.31% |
| 2014 Q2 | 63.63 Million EUR | -0.68% |
| 2014 FY | 66.03 Million EUR | 1.75% |
| 2014 Q4 | 66.03 Million EUR | 2.13% |
| 2014 Q3 | 64.65 Million EUR | 1.61% |
| 2014 Q1 | 64.06 Million EUR | -1.29% |
| 2013 Q1 | - EUR | -100.0% |
| 2013 Q2 | 46.75 Million EUR | 0.0% |
| 2013 Q3 | 44.73 Million EUR | -4.32% |
| 2013 Q4 | 64.9 Million EUR | 45.08% |
| 2013 FY | 64.9 Million EUR | 1179.36% |
| 2012 Q2 | 4.6 Million EUR | 0.0% |
| 2012 Q4 | 5.07 Million EUR | 0.0% |
| 2012 FY | 5.07 Million EUR | -3.7% |
| 2011 Q4 | 5.26 Million EUR | 0.0% |
| 2011 Q2 | 6.16 Million EUR | 0.0% |
| 2011 FY | 5.26 Million EUR | -4.93% |
| 2010 Q2 | 5.75 Million EUR | 0.0% |
| 2010 Q4 | 5.54 Million EUR | 0.0% |
| 2010 FY | 5.54 Million EUR | 3.36% |
| 2009 FY | 5.36 Million EUR | 38.74% |
| 2009 Q4 | 5.36 Million EUR | 0.0% |
| 2008 FY | 3.86 Million EUR | 23.69% |
| 2007 FY | 3.12 Million EUR | 8.17% |
| 2006 FY | 2.88 Million EUR | 6.61% |
| 2005 FY | 2.7 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -1.613% |
| IO Biotech, Inc. | 1.83 Million USD | -7119.576% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -134009.091% |
| Organovo Holdings, Inc. | 888 Thousand USD | -14851.351% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -97399.504% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -1923.594% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -15838.535% |
| Savara Inc. | 26.34 Million USD | -403.902% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -51965.882% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -494.679% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -3999.51% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -13033.202% |
| Aptose Biosciences Inc. | 621 Thousand USD | -21279.71% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -1237.039% |
| Century Therapeutics, Inc. | 46.65 Million USD | -184.556% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -1860.254% |
| Precision BioSciences, Inc. | 7.72 Million USD | -1619.125% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 25.441% |
| Kura Oncology, Inc. | 9.33 Million USD | -1322.718% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 88.87 Thousand USD | -149295.747% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -397.258% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -11701.6% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -1314.683% |
| Autolus Therapeutics plc | 47.91 Million USD | -177.096% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -603390.909% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -2606.237% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -1538.1% |
| IGM Biosciences, Inc. | 34.67 Million USD | -282.926% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 23.588% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -3174.778% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -90249.713% |
| Opthea Limited | 200.53 Million USD | 33.793% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -143.299% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -190.565% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -1220.549% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -2207.003% |
| Surrozen, Inc. | 882 Thousand USD | -14953.061% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -98174.599% |
| Ovid Therapeutics Inc. | 30 Million USD | -342.56% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -27.248% |
| Acelyrin, Inc. | 1.19 Million USD | -11019.598% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -75.387% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -142501.822% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -412.479% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -284.211% |
| ADMA Biologics, Inc. | 130.59 Million USD | -1.665% |
| PureTech Health plc | 18.25 Million USD | -627.496% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -91464.138% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -9486.137% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -1086.382% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -69.5% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -121705.505% |
| ChromaDex Corporation | 2.57 Million USD | -5056.039% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -147217.03% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 30.102% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -86.482% |
| Better Therapeutics, Inc. | 10.34 Million USD | -1183.031% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -474.132% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -42.711% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -296.145% |
| Seer, Inc. | 25.96 Million USD | -411.354% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -10176.161% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -22364.975% |
| Gritstone bio, Inc. | 40.14 Million USD | -230.729% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -7219.074% |
| Avid Bioservices, Inc. | 153.59 Million USD | 13.559% |
| Insmed Incorporated | 1.19 Billion USD | 88.874% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -3065.665% |
| Avalo Therapeutics, Inc. | 2 Million USD | -6538.4% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -36.368% |
| MediWound Ltd. | 6.35 Million USD | -1990.835% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -31.979% |
| Fortress Biotech, Inc. | 60.85 Million USD | -118.167% |
| OmniAb, Inc. | 22.07 Million USD | -501.441% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -30.749% |
| Zai Lab Limited | 8.04 Million USD | -1549.907% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 68.877% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -345.246% |
| Veracyte, Inc. | 7.52 Million USD | -1664.359% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -2916.084% |
| FibroGen, Inc. | 89.69 Million USD | -48.018% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -14130.225% |
| ContextLogic Inc. | 6 Million USD | -2112.8% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -96108.696% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -3392.976% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 97.401% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -120.102% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -358732.432% |
| ImmuCell Corporation | 10.54 Million USD | -1159.599% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 91.867% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -2107.282% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -7219.074% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -263.201% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -334.251% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -193.501% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -196.344% |
| Vaxxinity, Inc. | 13.26 Million USD | -901.116% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 83.634% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -29466.22% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -602.662% |
| Senti Biosciences, Inc. | 33.53 Million USD | -295.873% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -49625.843% |
| 89bio, Inc. | 24.79 Million USD | -435.463% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -26.92% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -346634.22% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -2878.197% |
| Ardelyx, Inc. | 51.54 Million USD | -157.567% |
| Pluri Inc. | 29.05 Million USD | -356.986% |
| Prothena Corporation plc | 10.72 Million USD | -1138.392% |
| Pulmatrix, Inc. | 8.32 Million USD | -1494.428% |
| Celularity Inc. | 26.17 Million USD | -407.193% |
| MeiraGTx Holdings plc | 72.11 Million USD | -84.096% |
| Omeros Corporation | 329.7 Million USD | 59.731% |
| Ainos, Inc. | 5.92 Million USD | -2142.113% |
| Humacyte, Inc. | 38.6 Million USD | -243.959% |
| Mesoblast Limited | 100.48 Million USD | -32.13% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -8131.122% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -3611.714% |
| Blueprint Medicines Corporation | 610.96 Million USD | 78.269% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -9006.173% |
| Summit Therapeutics Inc. | 103.29 Million USD | -28.539% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -172.714% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -37.232% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -28208.742% |
| Cytokinetics, Incorporated | 607.37 Million USD | 78.141% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -1427.474% |
| Nutriband Inc. | 79.82 Thousand USD | -166221.75% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -2860.928% |
| Roivant Sciences Ltd. | 477.85 Million USD | 72.216% |
| Evogene Ltd. | 10.65 Million USD | -1146.297% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -17392.49% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -504222.723% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 92.351% |
| BioLineRx Ltd. | 6.62 Million USD | -1903.138% |
| Atai Life Sciences N.V. | 15.21 Million USD | -772.842% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -8356.561% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -61.894% |
| MediciNova, Inc. | 410.66 Thousand USD | -32230.395% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -9598.174% |
| MiMedx Group, Inc. | 48.09 Million USD | -176.031% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 53.286% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -6075.256% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -22479.592% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -1052.3% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -485.01% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -1227.016% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -1054.003% |
| Allakos Inc. | 38.21 Million USD | -247.424% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -1438.626% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -15781.34% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -50.282% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -2719.452% |
| Precigen, Inc. | 5.89 Million USD | -2152.214% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 118.51 Million USD | -12.023% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -1218.582% |
| Incyte Corporation | 29.16 Million USD | -355.277% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -258.068% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -1580.82% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 223 Million USD | 40.465% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -431.838% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -885020.0% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -47625.655% |
| UroGen Pharma Ltd. | 98.55 Million USD | -34.72% |
| Sutro Biopharma, Inc. | 149.11 Million USD | 10.962% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | 137.00 USD | -96910848.905% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -2681.647% |
| Chimerix, Inc. | 125 Thousand USD | -106114.4% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -88264.137% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -525.144% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 7000.00 USD | -1896585.714% |
| OncoCyte Corporation | 2.2 Million USD | -5923.956% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -198342.568% |
| Purple Biotech Ltd. | 163 Thousand USD | -81352.761% |
| NextCure, Inc. | 5.94 Million USD | -2131.77% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 89.77 Million USD | -47.891% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -7065.03% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 30.463% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -18037.705% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 168.01 Million USD | 20.979% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 1.48 Million USD | -8816.588% |
| Daré Bioscience, Inc. | 3.91 Million USD | -3292.412% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -231.257% |
| BeiGene, Ltd. | 197.61 Million USD | 32.816% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -14465.88% |
| Alector, Inc. | 30.45 Million USD | -335.934% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -155.869% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 16.87 Million USD | -687.007% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -41915.19% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 77.614% |
| Histogen Inc. | 4.38 Million USD | -2928.467% |
| Fortress Biotech, Inc. | 60.85 Million USD | -118.167% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -2036.939% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -133.36% |
| Galecto, Inc. | 66 Thousand USD | -201063.636% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 79.412% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | 4.003% |
| Molecular Templates, Inc. | 9.74 Million USD | -1262.841% |
| PDS Biotechnology Corporation | 19.5 Million USD | -580.646% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -6605.455% |
| Amarin Corporation plc | 8.73 Million USD | -1419.606% |
| TG Therapeutics, Inc. | 100.11 Million USD | -32.612% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -2360.033% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -14206.897% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -660.108% |
| Onconetix, Inc. | 118.85 Thousand USD | -111603.98% |
| MacroGenics, Inc. | 30.19 Million USD | -339.687% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -25580.464% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 13.54 Million USD | -880.559% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 35.851% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -1410.616% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -676.739% |
| SciSparc Ltd. | 24 Thousand USD | -553100.0% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -61.879% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -498.458% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 34.208% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -173.737% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 94.333% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -577152.174% |
| 2seventy bio, Inc. | 244.01 Million USD | 45.59% |
| Clene Inc. | 7.15 Million USD | -1756.376% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 46.382% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -101355.721% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -1809.507% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 4.66 Million USD | -2749.099% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -1277.404% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -519.052% |
| Entera Bio Ltd. | 256 Thousand USD | -51762.5% |
| Trevena, Inc. | 35.23 Million USD | -276.829% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -568.823% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -412.459% |
| INmune Bio, Inc. | 397 Thousand USD | -33342.821% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -50408.055% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -2035.907% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -464.034% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -328.381% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -216.205% |
| NexImmune, Inc. | - USD | -Infinity% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -73660.0% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -88412.0% |
| Kronos Bio, Inc. | 25.37 Million USD | -423.141% |
| Innoviva, Inc. | 446.23 Million USD | 70.247% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 71.953% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 95.088% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -661.415% |
| Verastem, Inc. | 40.08 Million USD | -231.208% |
| ProKidney Corp. | 3.61 Million USD | -3577.784% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.13 Million USD | -11553.543% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -14084.615% |
| Statera Biopharma, Inc. | 11.43 Million USD | -1061.459% |
| ImmunityBio, Inc. | 836.95 Million USD | 84.137% |
| Korro Bio, Inc. | 31.21 Million USD | -325.32% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 64.808% |
| Kineta, Inc. | 150 Thousand USD | -88412.0% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -4064.617% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -3832.4% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -887.931% |
| Celularity Inc. | 26.17 Million USD | -407.193% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -179.188% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 17.67 Million USD | -651.205% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -101.907% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -39.478% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | 100 Million USD | -32.768% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -46.058% |
| Annexon, Inc. | 29.19 Million USD | -354.841% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -105.437% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -11733.155% |
| Elicio Therapeutics, Inc. | 6 Million USD | -2110.221% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -925.632% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 90.519% |
| Vor Biopharma Inc. | 31.83 Million USD | -317.116% |
| Eyenovia, Inc. | 8.95 Million USD | -1382.244% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -41782.65% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -102.208% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -209.649% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -422.626% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -177.757% |
| Immunocore Holdings plc | 82.64 Million USD | -60.651% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -260.41% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -85.066% |
| Alkermes plc | 287.73 Million USD | 53.857% |
| Arcellx, Inc. | 50.84 Million USD | -161.144% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -15660.89% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -207.689% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -12484.645% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -19922.35% |
| Moolec Science SA | 99.04 Thousand USD | -133946.807% |
| Biomea Fusion, Inc. | 7.83 Million USD | -1595.632% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 35.05 Million USD | -278.785% |
| Mereo BioPharma Group plc | 5.3 Million USD | -2405.057% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -209.67% |
| Royalty Pharma plc | 6.13 Billion USD | 97.836% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -7985.749% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -97523.529% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -418172.321% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -473.561% |
| Humacyte, Inc. | 38.6 Million USD | -243.959% |
| Structure Therapeutics Inc. | 4.01 Million USD | -3208.448% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -7015.113% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| aTyr Pharma, Inc. | 13.76 Million USD | -864.393% |
| Notable Labs, Ltd. | 1.52 Million USD | -8600.393% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Mustang Bio, Inc. | 1.97 Million USD | -6612.235% |
| Immunovant, Inc. | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -818.501% |
| Vericel Corporation | 81.85 Million USD | -62.197% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 91.144% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -500.461% |
| Orgenesis Inc. | 19.06 Million USD | -596.323% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -7632.557% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -97523.529% |
| GH Research PLC | 631 Thousand USD | -20940.887% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -2019.54% |
| PepGen Inc. | 17.1 Million USD | -676.421% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -27910.127% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -22870.242% |
| Pharming Group N.V. | 166.1 Million USD | 20.07% |
| XOMA Corporation | 118.51 Million USD | -12.023% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -20580.374% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 117.62 Million USD | -12.871% |
| Xencor, Inc. | 14.64 Million USD | -806.761% |
| Replimune Group, Inc. | 71.99 Million USD | -84.426% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -560.57% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -1795.061% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 1.18 Million USD | -11066.358% |
| Windtree Therapeutics, Inc. | 15 Million USD | -785.12% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -9190.973% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -19922.35% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -1327580.0% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -19253.936% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -5137.396% |
| scPharmaceuticals Inc. | 38.81 Million USD | -242.089% |
| HilleVax, Inc. | 25.24 Million USD | -425.939% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -166.191% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2961.287% |
| Immunic, Inc. | 639 Thousand USD | -20677.465% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.05 Million USD | -4240.951% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -102029.231% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2961.287% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -18928.973% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -2212700.0% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 65.769% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 224.41 Million USD | 40.839% |
| DBV Technologies S.A. | 4.52 Million USD | -2833.451% |
| Compugen Ltd. | 719 Thousand USD | -18365.647% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -9808.06% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -3422.632% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -12690.751% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -2520.766% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -3424.502% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -57.02% |
| Adicet Bio, Inc. | 17.7 Million USD | -649.975% |
| Prime Medicine, Inc. | 4.35 Million USD | -2947.234% |
| Aditxt, Inc. | 1.04 Million USD | -12644.782% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -14.971% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -866.499% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -198523.661% |
| PolyPid Ltd. | 6.37 Million USD | -1981.329% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -45.245% |
| Invivyd, Inc. | 722 Thousand USD | -18288.92% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -4540948.592% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -152.133% |
| CorMedix Inc. | 517.01 Thousand USD | -25579.818% |
| Instil Bio, Inc. | 81.42 Million USD | -63.052% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -11958.856% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 31.073% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -367.444% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -3371.059% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -2266.631% |
| AbCellera Biologics Inc. | 71.22 Million USD | -86.414% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -77.201% |
| Surrozen, Inc. | 882 Thousand USD | -14953.061% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -476.625% |
| Verona Pharma plc | 48.37 Million USD | -174.461% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -18.89% |
| Evaxion Biotech A/S | 8.48 Million USD | -1464.047% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -105.158% |
| Shattuck Labs, Inc. | 3.4 Million USD | -3798.062% |
| AlloVir, Inc. | 16.64 Million USD | -697.501% |
| BioVie Inc. | 349.89 Thousand USD | -37845.206% |
| Codexis, Inc. | 12.24 Million USD | -984.44% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -28762.609% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -97399.504% |
| Agenus Inc. | 137.32 Million USD | 3.318% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -75188.781% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -215796.969% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -557.105% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.03 Million USD | -258.489% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -9006.173% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -380.678% |
| IN8bio, Inc. | 3.37 Million USD | -3829.21% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -12765.116% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -33.424% |
| Liquidia Corporation | 2.36 Million USD | -5516.244% |
| Quantum-Si incorporated | 13.73 Million USD | -866.499% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -1282.424% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -10908.955% |
| United Therapeutics Corporation | 300 Million USD | 55.744% |
| Solid Biosciences Inc. | 23.94 Million USD | -454.563% |
| Immuneering Corporation | 4.16 Million USD | -3089.352% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -2266.631% |
| uniQure N.V. | 130.06 Million USD | -2.078% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -1530.656% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -126.605% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -967.782% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -202633.283% |
| Cue Biopharma, Inc. | 4.2 Million USD | -3059.638% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -358732.432% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -340.548% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immunome, Inc. | 1.34 Million USD | -9808.06% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -24670.149% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -1340.625% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -1103.474% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Altimmune, Inc. | 175 Thousand USD | -75767.429% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -166.752% |
| Rallybio Corporation | 173 Thousand USD | -76644.509% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -156097.647% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -78928.571% |
| Moolec Science SA | 99.04 Thousand USD | -133946.807% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -68337.113% |
| NeurAxis, Inc. | 27.07 Thousand USD | -490343.648% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 74.404% |
| Lumos Pharma, Inc. | 6 Million USD | -2112.8% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -1340.625% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -665871.108% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -1237.039% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -693.003% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -166221.75% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -1021192.308% |
| argenx SE | 15.35 Million USD | -764.713% |
| Neurogene Inc. | 13.37 Million USD | -892.806% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 56.671% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -405.532% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 16.03 Million USD | -727.886% |
| Design Therapeutics, Inc. | 2.33 Million USD | -5588.432% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Achilles Therapeutics plc | 1.07 Million USD | -12239.033% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -181773.973% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -1779393.366% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 61.234% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -442.264% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -5210.741% |
| Palisade Bio, Inc. | 90 Thousand USD | -147420.0% |
| Beam Therapeutics Inc. | 159.91 Million USD | 16.974% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -221838.417% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -13176.8% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -227.757% |
| Athira Pharma, Inc. | 1.21 Million USD | -10809.449% |
| Vaccinex, Inc. | 26 Thousand USD | -510546.154% |
| HCW Biologics Inc. | 6.3 Million USD | -2005.985% |
| XOMA Corporation | 118.51 Million USD | -12.023% |
| Nektar Therapeutics | 112.62 Million USD | -17.885% |
| Arvinas, Inc. | 800 Thousand USD | -16496.0% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -818.501% |
| Merus N.V. | 10.48 Million USD | -1165.904% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -791.958% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -888.666% |
| Rezolute, Inc. | 1.66 Million USD | -7898.072% |
| Clene Inc. | 7.15 Million USD | -1756.376% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -180911.071% |
| BeyondSpring Inc. | 3.36 Million USD | -3846.73% |
| Synlogic, Inc. | 12.49 Million USD | -962.909% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -306.565% |
| Krystal Biotech, Inc. | 6.62 Million USD | -1905.559% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 22.321% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -2114.276% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -280172.741% |
| MannKind Corporation | 252.15 Million USD | 47.346% |
| Ikena Oncology, Inc. | 7.18 Million USD | -1749.136% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -66617.588% |
| Gossamer Bio, Inc. | 197.4 Million USD | 32.743% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -25432.308% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 52.807% |
| Mural Oncology plc | 8.91 Million USD | -1389.934% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -203.567% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -9145.682% |
| Champions Oncology, Inc. | 6.09 Million USD | -2079.025% |
| REGENXBIO Inc. | 82.22 Million USD | -61.475% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -26775.95% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -2894.317% |
| Vaxart, Inc. | 2.62 Million USD | -4961.685% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -48778.074% |
| Cellectis S.A. | 36.24 Million USD | -266.348% |
| Longeveron Inc. | 1.44 Million USD | -9069.061% |
| Repare Therapeutics Inc. | 1.01 Million USD | -13045.347% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 88.277% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -196.562% |
| Revolution Medicines, Inc. | 80.57 Million USD | -64.776% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -4038.653% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -74910.169% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -107841.463% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 81.68% |
| Denali Therapeutics Inc. | 44.98 Million USD | -195.165% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -961.783% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -98174.599% |
| Passage Bio, Inc. | 22.92 Million USD | -479.242% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -2098.51% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -20420.556% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -64.776% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -558.408% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -26995.51% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -32484.543% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -11075.758% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -28390.987% |
| OmniAb, Inc. | 22.07 Million USD | -501.441% |
| Anew Medical, Inc. | 1.54 Million USD | -8521.299% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -349.148% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -1369.811% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -327.044% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -3174.778% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -157.517% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -1985.252% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -839.684% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -19657.143% |
| Alumis Inc. Common Stock | 30.86 Million USD | -330.227% |
| Equillium, Inc. | 384 Thousand USD | -34475.0% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -2055.675% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | 12.103% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -171.626% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -110262.255% |
| Dominari Holdings Inc. | 3.02 Million USD | -4284.676% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -671361.083% |
| vTv Therapeutics Inc. | 169 Thousand USD | -78460.947% |
| Bio-Techne Corporation | 319 Million USD | 58.38% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -132.975% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 25.648% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -761.738% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -972.18% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -2661.972% |
| Nkarta, Inc. | 82.27 Million USD | -61.381% |
| BioCardia, Inc. | 982 Thousand USD | -13420.163% |
| Iterum Therapeutics plc | 18.95 Million USD | -600.401% |